01 1Nobilus Ent Tomasz Kozluk
01 1Masung LS Co., Ltd.
01 1Digoxin
01 1Poland
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-03-09
Registration Number : 20210309-209-J-739
Manufacturer Name : Nobilus Ent Tomasz Kozluk
Manufacturer Address : ul. Metalowa 6a, 99-300 Kutno, Poland
42
PharmaCompass offers a list of Digoxin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Digoxin manufacturer or Digoxin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Digoxin manufacturer or Digoxin supplier.
A Lanicor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lanicor, including repackagers and relabelers. The FDA regulates Lanicor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lanicor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lanicor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lanicor supplier is an individual or a company that provides Lanicor active pharmaceutical ingredient (API) or Lanicor finished formulations upon request. The Lanicor suppliers may include Lanicor API manufacturers, exporters, distributors and traders.
click here to find a list of Lanicor suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Lanicor Drug Master File in Korea (Lanicor KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Lanicor. The MFDS reviews the Lanicor KDMF as part of the drug registration process and uses the information provided in the Lanicor KDMF to evaluate the safety and efficacy of the drug.
After submitting a Lanicor KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Lanicor API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Lanicor suppliers with KDMF on PharmaCompass.
